57 related articles for article (PubMed ID: 19715837)
21. Therapeutical aspects and outcome of HIV/HCV coinfected patients treated with pegylated interferon plus ribavirin in an Italian cohort.
Righi E; Beltrame A; Bassetti M; Lindstrom V; Mazzarello G; Dentone C; Di Biagio A; Ratto S; Viscoli C
Infection; 2008 Aug; 36(4):358-61. PubMed ID: 18642111
[TBL] [Abstract][Full Text] [Related]
22. [Good virological response to pegylated interferon alfa monotherapy of chronic hepatitis C infection in hemodialysis patient].
Caro P; Núñez A; Delgado R; Dapena F; Amann R
Nefrologia; 2007; 27(1):77-80. PubMed ID: 17402884
[TBL] [Abstract][Full Text] [Related]
23. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
[TBL] [Abstract][Full Text] [Related]
24. Management of hepatitis C in HIV infected and other immunocompromised individuals.
Seth AK
Trop Gastroenterol; 2006; 27(3):111-7. PubMed ID: 17310553
[TBL] [Abstract][Full Text] [Related]
25. Retention rate and side effects in a prospective trial on hepatitis C treatment with pegylated interferon alpha-2a and ribavirin in opioid-dependent patients.
Ebner N; Wanner C; Winklbaur B; Matzenauer C; Jachmann CA; Thau K; Fischer G
Addict Biol; 2009 Apr; 14(2):227-37. PubMed ID: 19291011
[TBL] [Abstract][Full Text] [Related]
26. Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b.
Venezia G; Licata A; Di Marco V; Craxì A; Almasio PL
Dig Liver Dis; 2005 Nov; 37(11):882-5. PubMed ID: 16169301
[TBL] [Abstract][Full Text] [Related]
27. Modeling hepatitis C virus therapies combining drugs and lectin affinity plasmapheresis.
Tullis RH; Duffin RP; Ichim TE; Joyce JA; Levin NW
Blood Purif; 2010; 29(2):210-5. PubMed ID: 20093829
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of pegylated interferon plus ribavirin in HIV and hepatitis C virus-coinfected patients with advanced immunosuppression.
Mira JA; Gutiérrez-Valencia A; Gil Ide L; Merino D; Rivero A; Ríos-Villegas MJ; Delgado M; González-Serrano M; Collado A; Torres-Tortosa M; Omar M; López-Ruz MA; Macías J; Arponen S; Pineda JA
Clin Infect Dis; 2009 Oct; 49(8):e84-91. PubMed ID: 19772388
[TBL] [Abstract][Full Text] [Related]
29. Overcoming a treatment barrier in treating hepatitis C in dialysis patients.
Lapumnuaypol K; Feyssa E
Semin Dial; 2018 Mar; 31(2):193. PubMed ID: 29405426
[No Abstract] [Full Text] [Related]
30. Occult hepatitis C virus infection in dialysis patients: does it need special attention?
Rezaee-Zavareh MS; Ramezani-Binabaj M; Einollahi B
Saudi J Kidney Dis Transpl; 2015 Mar; 26(2):368-9. PubMed ID: 25758893
[No Abstract] [Full Text] [Related]
31. Hepatitis C in Patients With RenalDisease: A Deeper Dive Into the KDIGO Guideline.
Terrault NA
Hepatology; 2018 Nov; 68(5):2035-2038. PubMed ID: 29672896
[No Abstract] [Full Text] [Related]
32. Meta-Analysis: Limits and Benefits.
Bardelli F; Messori A; Rampazzo R; Alberti A; Martini N
Clin Drug Investig; 1995 Sep; 10(3):188-90. PubMed ID: 27519204
[No Abstract] [Full Text] [Related]
33. Hepatitis C and kidney disease: A narrative review.
Barsoum RS; William EA; Khalil SS
J Adv Res; 2017 Mar; 8(2):113-130. PubMed ID: 28149647
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus infection in nephrology patients.
Rostaing L; Izopet J; Kamar N
J Nephropathol; 2013 Oct; 2(4):217-33. PubMed ID: 24475454
[TBL] [Abstract][Full Text] [Related]
35. Management of the kidney transplant patient with chronic hepatitis C infection.
Tang IY; Walzer N; Aggarwal N; Tzvetanov I; Cotler S; Benedetti E
Int J Nephrol; 2011; 2011():245823. PubMed ID: 21603155
[TBL] [Abstract][Full Text] [Related]
36. Treatment of chronic hepatitis C virus infection in dialysis patients: an update.
Weclawiak H; Kamar N; Ould-Mohamed A; Cardeau-Desangles I; Izopet J; Rostaing L
Hepat Res Treat; 2010; 2010():267412. PubMed ID: 21152180
[TBL] [Abstract][Full Text] [Related]
37. Results of hepatitis C virus treatment in patients on hemodialysis: data from published meta-analyses in 2008.
Casanovas Taltavull T; Baliellas Comellas C; Cruzado Garrit JM
Transplant Proc; 2009; 41(6):2082-4. PubMed ID: 19715837
[TBL] [Abstract][Full Text] [Related]
38. Treatment of hepatitis C in hemodialysis patients with pegylated interferon alpha-2a as monotherapy.
Sikole A; Dzekova P; Selja N; Gaseva M; Nikolov IG; Zabzun M; Muharemi S; Asani A; Amitov V; Mena S; Grunevska V; Ivanovski L; Polenakovic M
Ren Fail; 2007; 29(8):961-6. PubMed ID: 18067041
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of chronic hepatitis C virus infection in hemodialysis patients].
Kaya S
Mikrobiyol Bul; 2008 Jul; 42(3):525-34. PubMed ID: 18822900
[TBL] [Abstract][Full Text] [Related]
40. Preliminary results of treatment with pegylated interferon alpha 2A for chronic hepatitis C virus in kidney transplant candidates on hemodialysis.
Casanovas-Taltavull T; Baliellas C; Llobet M; Cruzado JM; Castellote J; Casanova A; Niubó J; Valls C; Serrano T
Transplant Proc; 2007 Sep; 39(7):2125-7. PubMed ID: 17889113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
